Company Profile

Puma Biotechnology Inc Stock Price, News & Analysis

Ticker:
PBYI
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, Puma Biotechnology Inc is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.

Stock performance

8.04 USD (+4.96%)

Close

Last updated: June 23, 2026 at 00:00

409.23M USD

Market cap

Why the stock is moving

PBYI is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Puma Biotechnology Inc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Puma Biotechnology Inc is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.

Business Model Characteristics

Puma Biotechnology Inc follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.

Position Within the Biotechnology Landscape

Compared with more mature healthcare names, Puma Biotechnology Inc sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Puma Biotechnology Inc (PBYI)?

    Puma Biotechnology Inc (PBYI) most recently closed at 8.04 USD, a +4.96% move versus the previous session.

    What is the market cap of Puma Biotechnology Inc (PBYI)?

    Puma Biotechnology Inc currently has a market capitalization of 409.23M USD on BioPharmSignal.

    What does Puma Biotechnology Inc do?

    Puma Biotechnology Inc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

    On which exchange is PBYI stock listed?

    Puma Biotechnology Inc (PBYI) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Puma Biotechnology Inc is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.

    What is Puma?

    Puma Biotechnology Inc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

    Which conditions is Puma Biotechnology Inc targeting with Puma?

    Puma Biotechnology Inc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

    What is Biotechnology?

    Puma Biotechnology Inc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.